1 |
Graefe T, Wollina U, Schulz H, Burgdorf W. Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000;200:331-333.
DOI
|
2 |
Natarajan K, Rai R, Pillai SB. Extra ocular sebaceous carcinoma: A rare case report. Indian Dermatol Online J. 2011;2:91-93.
DOI
|
3 |
Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115:158-165.
DOI
|
4 |
Lee JH, Shin HK, Jang TJ. A Case of Rapidly Growing Extraocular Sebaceous Carcinoma. Arch Craniofac Surg. 2014;15:32-35.
DOI
|
5 |
Park SK, Park J, Kim HU, Yun SK. Sebaceous Carcinoma: Clinicopathologic Analysis of 29 Cases in a Tertiary Hospital in Korea. J Korean Med Sci. 2017;32:1351-1359.
DOI
|
6 |
Ponti G, Lorena L, Carmela DG, Luca R, Monica P, Alessandra S, et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer. 2005;103:1018-1025.
DOI
|